PHARMACOKINETICS AND PHARMACODYNAMICS OF RAMIPRIL IN RENAL-FAILURE

被引：18

作者：

AURELL, M ^{[1
]}

DELIN, K ^{[1
]}

HERLITZ, H ^{[1
]}

LJUNGMAN, S ^{[1
]}

WITTE, PU ^{[1
]}

IRMISCH, R ^{[1
]}

机构：

[1] HOECHST AG,CLIN RES,D-6230 FRANKFURT 80,FED REP GER

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 1987年 / 59卷 / 10期

关键词：

D O I：

10.1016/0002-9149(87)90056-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：D65 / D69

页数：5

共 13 条

[1]

BADIAN M, 1986, NAUNYNSCHMIEDEBERGS, P393

[2]

BECKER RHA, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1411

[3]

ECKERT HG, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1251

[4]

FELDER K, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1452

[5] PHARMACOKINETICS OF ENALAPRIL IN NORMAL SUBJECTS AND PATIENTS WITH RENAL IMPAIRMENT [J].

KELLY, JG ;

DOYLE, G ;

DONOHUE, J ;

LAHER, M ;

VANDENBURG, MJ ;

CURRIE, WJC ;

COOPER, WD .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (01) :63-69

[6]

KONDO K, 1986, JPN PHARMACOL THER, V14, P339

[7] THE EFFECT OF RENAL-FUNCTION ON ENALAPRIL KINETICS [J].

LOWENTHAL, DT ;

IRVIN, JD ;

MERRILL, D ;

SARIS, S ;

ULM, E ;

GOLDSTEIN, S ;

HICHENS, M ;

KLEIN, L ;

TILL, A ;

HARRIS, K .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (06) :661-666

[8]

SHIONOIRI H, 1986, CURR THER RES CLIN E, V40, P74

[9] EFFECTS OF THE NEW ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, RAMIPRIL, IN PATIENTS WITH ESSENTIAL-HYPERTENSION [J].

STUMPE, KO ;

OVERLACK, A ;

KOLLOCH, R ;

SCHATZ, J ;

WITTE, PU ;

PAHNKE, K .

KLINISCHE WOCHENSCHRIFT, 1986, 64 (12) :558-562

[10]

WITTE PU, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1448

← 1 2 →